426 380

Cited 4 times in

Cost-Effectiveness Analysis of HPV Vaccination: Comparing the General Population with Socially Vulnerable Individuals.

DC Field Value Language
dc.contributor.author박은철-
dc.date.accessioned2015-01-06T17:33:48Z-
dc.date.available2015-01-06T17:33:48Z-
dc.date.issued2014-
dc.identifier.issn1513-7368-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/100212-
dc.description.abstractBACKGROUND: After the WHO recommended HPV vaccination of the general population in 2009, government support of HPV vaccination programs was increased in many countries. However, this policy was not implemented in Korea due to perceived low cost-effectiveness. Thus, the aim of this study was to analyze the cost-utility of HPV vaccination programs targeted to high risk populations as compared to vaccination programs for the general population. MATERIALS AND METHODS: Each study population was set to 100,000 people in a simulation study to determine the incremental cost-utility ratio (ICUR), then standard prevalence rates, cost, vaccination rates, vaccine efficacy, and the Quality-Adjusted Life-Years (QALYs) were applied to the analysis. In addition, sensitivity analysis was performed by assuming discounted vaccination cost. RESULTS: In the socially vulnerable population, QALYs gained through HPV vaccination were higher than that of the general population (General population: 1,019, Socially vulnerable population: 5,582). The results of ICUR showed that the cost of HPV vaccination was higher for the general population than the socially vulnerable population. (General population: 52,279,255 KRW, Socially vulnerable population: 9,547,347 KRW). Compared with 24 million KRW/QALYs as the social threshold, vaccination of the general population was not cost-effective. In contrast, vaccination of the socially vulnerable population was strongly cost-effective. CONCLUSIONS: The results suggest the importance and necessity of government support of HPV vaccination programs targeted to socially vulnerable populations because a targeted approach is much more cost-effective. The implementation of government support for such vaccination programs is a critical strategy for decreasing the burden of HPV infection in Korea.-
dc.description.statementOfResponsibilityopen-
dc.format.extent8503~8508-
dc.relation.isPartOfASIAN PACIFIC JOURNAL OF CANCER PREVENTION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdolescent-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCase-Control Studies-
dc.subject.MESHCervical Intraepithelial Neoplasia/economics*-
dc.subject.MESHCervical Intraepithelial Neoplasia/prevention & control-
dc.subject.MESHCervical Intraepithelial Neoplasia/virology-
dc.subject.MESHChild-
dc.subject.MESHCost-Benefit Analysis*-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHImmunization Programs-
dc.subject.MESHMarkov Chains-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHPapillomaviridae/isolation & purification-
dc.subject.MESHPapillomavirus Infections/economics*-
dc.subject.MESHPapillomavirus Infections/prevention & control-
dc.subject.MESHPapillomavirus Infections/virology-
dc.subject.MESHPapillomavirus Vaccines/therapeutic use*-
dc.subject.MESHPrognosis-
dc.subject.MESHQuality-Adjusted Life Years-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHUterine Cervical Neoplasms/economics*-
dc.subject.MESHUterine Cervical Neoplasms/prevention & control-
dc.subject.MESHUterine Cervical Neoplasms/virology-
dc.subject.MESHYoung Adult-
dc.titleCost-Effectiveness Analysis of HPV Vaccination: Comparing the General Population with Socially Vulnerable Individuals.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Preventive Medicine (예방의학)-
dc.contributor.googleauthorKyu-Tae Han-
dc.contributor.googleauthorSun Jung Kim-
dc.contributor.googleauthorSeo Yoon Lee-
dc.contributor.googleauthorEun-Cheol Park-
dc.identifier.doi10.7314/APJCP.2014.15.19.8503-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01618-
dc.relation.journalcodeJ00255-
dc.identifier.eissn2476-762X-
dc.identifier.pmid25339055-
dc.contributor.alternativeNamePark, Eun Chul-
dc.contributor.affiliatedAuthorPark, Eun Chul-
dc.citation.volume15-
dc.citation.number19-
dc.citation.startPage8503-
dc.citation.endPage8508-
dc.identifier.bibliographicCitationASIAN PACIFIC JOURNAL OF CANCER PREVENTION, Vol.15(19) : 8503-8508, 2014-
dc.identifier.rimsid51751-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.